Home > Clinical Trials
Check All Search

Saved trials

Completed
NCT03366428
Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2-Expressing Breast Cancer
51 Enrollment(s)
7 Study location(s)
Interventional (Phase I)
Malignant Neoplasm of Breast
Completed
NCT03153150
Start or STop Anticoagulants Randomised Trial (SoSTART)
203 Enrollment(s)
67 Study location(s)
Interventional (Phase III)
Intracranial Hemorrhages
Intracranial Hemorrhage, Hypertensive
Subarachnoid Hemorrhage
Subdural Hematoma
Intraventricular Hemorrhage
Atrial Fibrillation
Atrial Flutter
Small Vessel Cerebrovascular Disease
Microhaemorrhage
Completed
NCT02943785
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
1,426 Enrollment(s)
230 Study location(s)
Interventional (Phase III)
Atrial Fibrillation
Not yet recruiting
NCT05110898
Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension.
400 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Hypertension
Hypertension,Essential
Completed
NCT03329690
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]
233 Enrollment(s)
66 Study location(s)
Interventional (Phase II)
Neoplasm, Gastrointestinal
Recruiting
NCT05183178
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
16,000 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Acute Coronary Syndrome
Terminated
NCT01452152
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
9 Enrollment(s)
5 Study location(s)
Interventional (Phase IV)
Cardiovascular Diseases
Acute Coronary Syndrome
Active, not recruiting
NCT04112589
A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment
63 Enrollment(s)
20 Study location(s)
Interventional (Phase I|Phase II)
Acute Myeloid Leukemia